India全球化資本 IGC 深 滬
已收盤 05-08 16:00:00 美东时间
0.311
-0.008
-2.54%
華盛通- 最 高0.3197
- 今 開0.315
- 成交量 44.76万股
- 最 低 0.306
- 昨 收 0.3191
- 總市值 3072.56万
- 52周最高 0.4985
- 市盈率 靜 --
- 換手率 0.45%
- 52周最低 0.242
- 委 比 -60.00%
- 總股本 9879.61万
- 歷史最高 14.58
- 量 比 0.83
- 振 幅 4.29%
- 歷史最低 0.242
- 每 手 1
- 風險率 0.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多IGC Pharma Receives Authorization In Colombia To Synthesize, Formulate, And Conduct Development Activities Involving Psilocybin At Its R&D Facility In Bogotá
Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Phase 2 CALMA trial approaching completionPOTOMAC, MD / ACCESS Newswire / April 20, 2026 / IGC Pharma, Inc. (NYSE:IGC)
04-20 20:33
美股大行评级 | 瑞银上调美光科技目标价从510升至535美元；巴克莱下调Robinhood 目标价从124降至89美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5美元升至5.25美元；Benchmark：维持Direct Digital Holdings"投机性买入"评级，目标价从2美元升至8美元
04-09 10:15
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.25
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5 to $5.25.
04-08 17:56
'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_read=1773920530418
03-19 22:30
IGC Pharma Q3 EPS $(0.01) Beats $(0.02) Estimate, Sales $213.000K Miss $325.000K Estimate
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent increase over losses of $(0.02) per share from the same period
03-19 21:25
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.75 to $5.
02-23 18:00
'GOP Congressman Isn't Sure Marijuana Rescheduling Is A DOJ 'Priority,' But Remains Optimistic About Progress Under Trump' - Marijuana Moment
https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-but-remains-optimistic-about-progress-under-trump/
02-11 00:19
IGC Pharma Expands Phase 2 CALMA Trial Into Colombia
- Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst -
02-09 21:38
IGC Pharma Q2 EPS $(0.02), Inline, Sales $191.000K Miss $325.000K Estimate
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $191.000 thousand
2025-11-17 21:38
